Barlow G H, Summaria L, Robbins K C
Biochemistry. 1984 May 22;23(11):2384-7. doi: 10.1021/bi00306a010.
Sedimentation velocity and sedimentation equilibrium studies have been carried out on the Glu- and Lys-plasminogen-streptokinase complexes as well as on the complexes formed by Val442-plasmin and the light (B) chain of plasmin. Sedimentation equilibrium molecular weights are consistent with a 1 to 1 molar complex in all cases and give values consistent with the differences in size of the plasminogen moieties. Sedimentation velocity determinations in the presence of protease inhibitors give values consistent with the conformational differences already reported for the Glu- and Lys-plasminogen molecules. However, unlike Glu-plasminogen, the addition of epsilon-aminocaproic acid or lysine does not alter the conformation of the Glu-plasminogen complex. The values of the sedimentation coefficient and the molecular weight of the plasmin and the Val442-plasmin-streptokinase complexes increase to those of a dimer when determined in the absence of active-site inhibitors but return to monomer values when these inhibitors are added. Thus, dimer formation requires the presence of an available active site in at least one of the two molecules involved and is reversible.
已对谷氨酸纤溶酶原 - 链激酶复合物、赖氨酸纤溶酶原 - 链激酶复合物以及由Val442 - 纤溶酶和纤溶酶轻链(B链)形成的复合物进行了沉降速度和沉降平衡研究。在所有情况下,沉降平衡分子量均与1:1摩尔复合物一致,且所得值与纤溶酶原部分大小的差异相符。在蛋白酶抑制剂存在下进行的沉降速度测定所得值与已报道的谷氨酸纤溶酶原和赖氨酸纤溶酶原分子的构象差异一致。然而,与谷氨酸纤溶酶原不同,添加ε - 氨基己酸或赖氨酸不会改变谷氨酸纤溶酶原复合物的构象。在无活性位点抑制剂的情况下测定时,纤溶酶以及Val442 - 纤溶酶 - 链激酶复合物的沉降系数和分子量值会增加到二聚体的值,但添加这些抑制剂后又会恢复到单体值。因此,二聚体的形成需要所涉及的两个分子中至少有一个存在可用的活性位点,并且是可逆的。